SCHEMBL15212062

SCHEMBL15212062

COc1cccc(C(CCCS)(c2ccccc2)c2ccccc2)c1OC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.40
KCNH2 Q12809 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
NFE2L2 Q16236 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ABCB1 P08183 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
NR3C2 P08235 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KCNA5 P22460 4/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15212175 0.84 NFE2L2 (0.39) KIF11KCNH2SMN1; SMN2NFE2L2ABCB1
SCHEMBL6855010 0.83 L3MBTL1 (0.39) KIF11KCNH2SMN1; SMN2NFE2L2ABCB1
SCHEMBL27938323 0.80 SMN1; SMN2 (0.40) KIF11KCNH2SMN1; SMN2NFE2L2CYP3A4
SCHEMBL5133757 0.80 NFE2L2 (0.40) SMN1; SMN2NFE2L2ABCB1ABCG2NR3C2
SCHEMBL7541639 0.80 KIF11 (0.40) KIF11KCNH2SMN1; SMN2NFE2L2NPC1
SCHEMBL15212075 0.78 CNR1 (0.35) KIF11KCNH2SMN1; SMN2NFE2L2ABCB1
SCHEMBL5859593 0.77 KIF11 (0.40) KIF11CNR1CNR2NPC1RAB9A
SCHEMBL27903876 0.74 NFE2L2 (0.42) KCNH2SMN1; SMN2NFE2L2ABCB1ABCG2
SCHEMBL7646522 0.74 NR3C2 (0.38) SMN1; SMN2NFE2L2ABCB1ABCG2CNR1
SCHEMBL16675115 0.74 NFE2L2 (0.45) SMN1; SMN2NFE2L2ABCB1ABCG2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013126034-A1 SYNTHESIS OF HIGH PURITY DMT-C3-DISULFIDE PHOSPHORAMIDITE CHEMGENES CORPORATION (US) 2013-08-29 WO disclosed